Abbott Laboratories (ABT) Land & Improvements (2009 - 2021)

Abbott Laboratories has disclosed Land & Improvements across 12 years of filings, most recently posting $525.0 million for Q4 2021.

• Land & Improvements for Q4 2021 came in at $525.0 million, down 2.42% year-over-year; the trailing twelve-month figure through Dec 2021 was $525.0 million (down 2.42% YoY), and the FY2021 annual result was $525.0 million, down 2.42% from the prior year.
• Land & Improvements came in at $525.0 million for Q4 2021 at Abbott Laboratories, down from $538.0 million in the prior quarter.
• In the past five years, Land & Improvements ranged from a high of $538.0 million in Q4 2020 to a low of $501.0 million in Q4 2018.
• The 5-year median for Land & Improvements is $525.0 million (2021), against an average of $521.8 million.
• Across the five-year window, Land & Improvements climbed 28.92% in 2017 and decreased 4.75% in 2018, its largest moves.
• Abbott Laboratories' Land & Improvements stood at $526.0 million in 2017, then slipped by 4.75% to $501.0 million in 2018, then grew by 3.59% to $519.0 million in 2019, then rose by 3.66% to $538.0 million in 2020, then slipped by 2.42% to $525.0 million in 2021.
• The last three Land & Improvements figures came in at $525.0 million (Q4 2021), $538.0 million (Q4 2020), and $519.0 million (Q4 2019), per Business Quant data.